Nasal spray found to be effective in treating hypoglycemia in diabetics

22 Dec 2015

1

A new nasal spray containing powdered glucagon - a hormone that rapidly increases blood sugar levels - might offer an effective rescue treatment for diabetics who felt  dizzy or even unconscious due to extremely low levels of blood sugar, HealthDay reported citing new research.

According to a research-stage clinical trial, the new nasal spray was about as effective as the only currently available treatment option for the  treatment of low blood sugar, or hypoglycemia.

The only treatment option currently available for the condition came in the form of an FDA-approved glucagon powder that was mixed with water and injected directly into muscle via a syringe.

In cases of mild and moderate levels of diabetes, adjusting one's blood sugar levels was as simple as sucking on a piece of candy but for severe cases, glucagon treatment could become necessary.

Researchers enrolled 75 participants, all adults with type 1 diabetes, in order to measure the nasal spray's effectiveness vis-à-vis the injection option. The participants of the trial were drawn from eight clinics, all located within in the US.

When it came to either treatment option, the researchers found that more than a third of the participants experienced nausea, while users of the nasal spray particularly tended to report feelings of discomfort in their head and facial regions.

Dr George Grunberger, professor at Wayne State University School of Medicine in Detroit and president of the American Association of Clinical Endocrinologists, the new spray if approved could become the go-to treatment for severe hypoglycemia as it was almost as effective as the current option and was very easy to administer.

He further said, ''This intranasal spray is a big deal. This is something which people have been crying for, for years. It was only a matter of time before something more practical came onto the market,'' nwitimes.com reported.

According to the researchers the new spray might be an apt solution as patients suffering from diabetes in order to maintain blood sugar levels, as sometimes patients excessive much insulin, which resulted in drastic drop in their blood sugar.

Latest articles

Nigeria and South Africa drive global stablecoin demand surge, study finds

Nigeria and South Africa drive global stablecoin demand surge, study finds

Cisco and Qunnect test real-world quantum network over New York fiber cables

Cisco and Qunnect test real-world quantum network over New York fiber cables

Uber to invest $100 million+ in autonomous charging hubs to accelerate robotaxi rollout

Uber to invest $100 million+ in autonomous charging hubs to accelerate robotaxi rollout

The $250 billion pivot: how 2026 became the year AI paid the rent

The $250 billion pivot: how 2026 became the year AI paid the rent

Sweden fines SBB over accounting violations, raising scrutiny on property sector

Sweden fines SBB over accounting violations, raising scrutiny on property sector

Ukraine-Russia peace talks enter second day in Geneva amid pressure concerns

Ukraine-Russia peace talks enter second day in Geneva amid pressure concerns

India asks university to exit AI summit after robot’s origin questioned

India asks university to exit AI summit after robot’s origin questioned

Redmond’s global reach: Microsoft on pace for $50 billion AI investment in the Global South

Redmond’s global reach: Microsoft on pace for $50 billion AI investment in the Global South

Data centres explore funding uranium projects as AI power demand surges, says NexGen CEO

Data centres explore funding uranium projects as AI power demand surges, says NexGen CEO